Beijing Chunlizhengda Medical Instruments
Market Cap
HK$8.5b
Last Updated
2021/01/26 10:09 UTC
Data Sources
Company Financials +
Executive Summary
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China. More Details
Snowflake Analysis
Flawless balance sheet with solid track record.
Similar Companies
Share Price & News
How has Beijing Chunlizhengda Medical Instruments's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1858 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: 1858's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
Market Performance
7 Day Return
3.7%
1858
14.9%
HK Medical Equipment
4.1%
HK Market
1 Year Return
-10.1%
1858
120.4%
HK Medical Equipment
16.9%
HK Market
Return vs Industry: 1858 underperformed the Hong Kong Medical Equipment industry which returned 120.4% over the past year.
Return vs Market: 1858 underperformed the Hong Kong Market which returned 16.9% over the past year.
Shareholder returns
| 1858 | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.7% | 14.9% | 4.1% |
| 30 Day | 3.5% | 18.4% | 14.8% |
| 90 Day | -34.0% | 26.9% | 21.4% |
| 1 Year | -10.1%-10.1% | 124.0%120.4% | 21.6%16.9% |
| 3 Year | 678.2%645.6% | 231.1%214.9% | -3.4%-13.7% |
| 5 Year | 843.3%784.3% | 348.3%309.6% | 67.8%39.1% |
Long-Term Price Volatility Vs. Market
How volatile is Beijing Chunlizhengda Medical Instruments's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Here's Why I Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is An Interesting Stock2 weeks ago | Simply Wall St
Estimating The Intrinsic Value Of Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)4 weeks ago | Simply Wall St
Did You Participate In Any Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Incredible 713% Return?Valuation
Is Beijing Chunlizhengda Medical Instruments undervalued compared to its fair value and its price relative to the market?
26.34x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1858 (HK$22.25) is trading above our estimate of fair value (HK$20.72)
Significantly Below Fair Value: 1858 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1858 is good value based on its PE Ratio (26.3x) compared to the HK Medical Equipment industry average (30.4x).
PE vs Market: 1858 is poor value based on its PE Ratio (26.3x) compared to the Hong Kong market (12x).
Price to Earnings Growth Ratio
PEG Ratio: 1858 is poor value based on its PEG Ratio (1.4x)
Price to Book Ratio
PB vs Industry: 1858 is overvalued based on its PB Ratio (7x) compared to the HK Medical Equipment industry average (3.7x).
Next Steps
Future Growth
How is Beijing Chunlizhengda Medical Instruments forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
18.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1858's forecast earnings growth (18.7% per year) is above the savings rate (1.5%).
Earnings vs Market: 1858's earnings (18.7% per year) are forecast to grow slower than the Hong Kong market (21.9% per year).
High Growth Earnings: 1858's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1858's revenue (25.9% per year) is forecast to grow faster than the Hong Kong market (14.6% per year).
High Growth Revenue: 1858's revenue (25.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1858's Return on Equity is forecast to be high in 3 years time (25.6%)
Next Steps
Past Performance
How has Beijing Chunlizhengda Medical Instruments performed over the past 5 years?
39.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1858 has a high level of non-cash earnings.
Growing Profit Margin: 1858's current net profit margins (27.5%) are higher than last year (24.9%).
Past Earnings Growth Analysis
Earnings Trend: 1858's earnings have grown significantly by 39.4% per year over the past 5 years.
Accelerating Growth: 1858's earnings growth over the past year (48.3%) exceeds its 5-year average (39.4% per year).
Earnings vs Industry: 1858 earnings growth over the past year (48.3%) exceeded the Medical Equipment industry 17.7%.
Return on Equity
High ROE: 1858's Return on Equity (26.8%) is considered high.
Next Steps
Financial Health
How is Beijing Chunlizhengda Medical Instruments's financial position?
Financial Position Analysis
Short Term Liabilities: 1858's short term assets (CN¥991.7M) exceed its short term liabilities (CN¥266.8M).
Long Term Liabilities: 1858's short term assets (CN¥991.7M) exceed its long term liabilities (CN¥90.2M).
Debt to Equity History and Analysis
Debt Level: 1858 is debt free.
Reducing Debt: 1858 has not had any debt for past 5 years.
Debt Coverage: 1858 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1858 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is Beijing Chunlizhengda Medical Instruments's current dividend yield, its reliability and sustainability?
0.54%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1858's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1858's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1858's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1858's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 1858 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1858's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.8yrs
Average management tenure
CEO
Chunbao Shi (50 yo)
10.33yrs
Tenure
CN¥1,336,369
Compensation
Mr. Chunbao Shi has been General Manager and Executive Chairman of the Board for Beijing Chunlizhengda Medical Instruments Co., Ltd. since September 2010. Mr. Shi has been Sales & Marketing Director of Bei...
CEO Compensation Analysis
Compensation vs Market: Chunbao's total compensation ($USD206.23K) is below average for companies of similar size in the Hong Kong market ($USD424.64K).
Compensation vs Earnings: Chunbao's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10.33yrs | CN¥1.34m | 32.87% CN¥ 2.8b | |
| Deputy GM & Executive Director | 10.33yrs | CN¥1.06m | 27.6% CN¥ 2.3b | |
| Chief Financial Officer | 2.5yrs | no data | no data | |
| Executive Director | 0.58yr | CN¥66.07k | no data | |
| Company Secretary | 5.83yrs | no data | no data |
5.8yrs
Average Tenure
48yo
Average Age
Experienced Management: 1858's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10.33yrs | CN¥1.34m | 32.87% CN¥ 2.8b | |
| Deputy GM & Executive Director | 10.33yrs | CN¥1.06m | 27.6% CN¥ 2.3b | |
| Executive Director | 0.58yr | CN¥66.07k | no data | |
| Independent Non-Executive Director | 0.33yr | no data | no data | |
| Employee Supervisor | 10.33yrs | CN¥34.47k | no data | |
| Independent Non-Executive Director | 3.58yrs | CN¥100.00k | no data | |
| Chairman of the Board of Supervisors | no data | no data | no data | |
| Supervisor | 4.5yrs | no data | no data | |
| Non-Executive Director | 0.58yr | no data | no data | |
| Independent Non-Executive Director | 0.58yr | no data | no data | |
| Shareholder Representative Supervisor | 0.33yr | no data | no data |
2.1yrs
Average Tenure
49yo
Average Age
Experienced Board: 1858's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Beijing Chunlizhengda Medical Instruments Co., Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Beijing Chunlizhengda Medical Instruments Co., Ltd.
- Ticker: 1858
- Exchange: SEHK
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$8.508b
- Shares outstanding: 345.85m
- Website: https://www.clzd.com/tc/index.php
Number of Employees
Location
- Beijing Chunlizhengda Medical Instruments Co., Ltd.
- No. 10 Xinmi Xi Er Road
- Southern District of Tongzhou
- Beijing
- Beijing Province
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1858 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Foreign Shares-Foreign Listed | HK | HKD | Mar 2015 |
Biography
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related produ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/26 10:09 |
| End of Day Share Price | 2021/01/26 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.